1921
Volume 12, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Summary

The procedure for the production of Rift Valley fever vaccine (RVF) has been described. Infectious vacuolating virus, SV 40, was present in 3 of 6 lots of inactivated RVF vaccine prepared from rhesus kidney cell cultures but was not detected in any of 5 sequential lots prepared in cell cultures. Moreover, formalin-killed RVF virus vaccines derived from the African green monkey kidney cells are as immunogenic as those produced in rhesus cell cultures. The addition of 2% human serum albumin increases the heat stability of lyophilized RVF vaccine. The lyophilized vaccine is as antigenic as the fluid vaccine for the immunization of man when used either for the primary series or as a booster dose. The formalin-killed RVF vaccine prepared in monkey kidney cell cultures with the pantropic virus has protected exposed laboratory workers, thereby indicating the efficacy of the vaccine.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1963.12.611
1963-07-01
2017-11-19
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1963.12.611
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error